Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 67 results found. Search for [ dr randeep guleria ]

Results 1 to 21 of 67
BusinessToday.In
January 19, 2021
According to experts, people have adopted a \"wait and watch\" approach which has resulted in low turnout at vaccination centres


BusinessToday.In
January 16, 2021
A total of 16,755 vaccinators participated in the vaccination process across India, the ministry added. Not a single case of hospitalisation post-vaccine administration has been reported yet


BusinessToday.In
January 16, 2021
In the first phase of the vaccination drive over 3 crores frontline healthcare workers are expected to be given the vaccine. They will receive either Covaxin or Covishield COVID-19 vaccines which were approved for emergency use earlier by the country's drug regulators


BusinessToday.In
New Delhi, January 16, 2021
After Prime Minister Narendra Modi rolled out the nationwide coronavirus immunisation programme, a sanitation worker at the All India Institute of Medical Sciences (AIIMS), New Delhi, became the first person to receive the COVID-19 vaccine shot on Saturday. The first shot was followed by vaccinating other doctors, nurses and healthcare workers, including All India Institute of Medical Sciences (AIIMS) chief Dr Randeep Guleria. Union health minister Harsh Vardhan was also present at the hospital, administering the launch of the vaccination drive. Watch the video for more.Also Read: PM Modi launches COVID-19 vaccination drive; urges Indians to take both shots, follow protocols


BusinessToday.In
January 16, 2021
In the consent form for getting Covaxin vaccine, recipients have been promised that in case of any adverse situation following the administration of the vaccine and if it is determined that the vaccine was the cause then the recipients will be given compensation and medical


BusinessToday.In
January 16, 2021
Coronavirus vaccination drive: It brings me great pride that Covishield is part of this historic effort, said Serum Institute CEO Adar Poonawalla


BusinessToday.In
January 16, 2021
PM Modi launches COVID-19 vaccination drive: Urging people to take the vaccine and to take the complete course PM Modi allayed fears surrounding the jab. He said that when it comes to vaccines, India enjoys scientific credibility


BusinessToday.In
January 16, 2021
COVID-19 vaccination drive India: Dr Guleria was the third person to take the shot. Before him, a sanitation worker and a healthcare worker got vaccinated


PTI
January 14, 2021
Around 3 lakh frontline healthcare workers will be inoculated at 2,934 sites across the country on the first day of January 16, according to Health Ministry


BusinessToday.In
New Delhi, January 7, 2021
Dr Randeep Guleria, Director, AIIMS, in an interview with India Today TV talks about the plan for vaccination in India. Healthcare and frontline workers, the aged and people with comorbidities would be given priority. Dr Guleria explains.Also Read: 10% COVID-19 vaccines will be wasted, says Centre; to cost Rs 1,320 crore more


BusinessToday.In
January 4, 2021
Defending Covaxin, the Bhart Biotech Chairman said that his company has tremendous experience in developing vaccines; more than 70 articles on data related to Covaxin have been published in various journals


BusinessToday.In
January 3, 2021
Calling it a great day for the country, AIIMS Director Dr Randeep Guleria said that initially Serum-AstraZeneca's Covishield will be administered to the people


BusinessToday.In
December 26, 2020
AIIMS Director Dr Randeep Guleria said the COVID-19 virus has undergone several mutations - an average of two per month - without leading to any changes in symptoms or treatment


BusinessToday.In
December 13, 2020
Dr Randeep Guleria, the head of All India Institute of Medical Sciences (AIIMS), is reportedly heading the team that's preparing the list of patients.


BusinessToday.In
December 6, 2020
Pfizer Inc submitted application to DCGI seeking emergency use authorisation on Dec 4; also seeks permission to import vaccine for sale and distribution in India


BusinessToday.In
December 5, 2020
DCGI VG Somani has said the CDSCO will facilitate analysis of interim clinical trial data at pre-defined stages. PM Modi says nearly eight vaccine candidates, out of which three are indigenously developed, are undergoing trials in India


BusinessToday.In
December 4, 2020
COVID-19 vaccine trial updates: AIIMS director Dr Randeep Guleria has pinned his hopes on the five coronavirus vaccine candidates which are in varying stages of trials across India


Rashi Bisaria
New Delhi, December 4, 2020
Focus on higher spending, stronger growth in next Budget: FM Sitharaman India's economy will return to growth in 2021/22 and higher spending in the budget due in February will lay the foundations for even stronger growth in the next four to five years, Finance Minister Nirmala Sitharaman told Reuters on Thursday. With the world's second highest cases of coronavirus despite a severe lockdown of its 1.3 billion people early on in the pandemic, India's economy is expected to contract nearly 10...


BusinessToday.In
December 3, 2020
Speaking on COVID-19 vaccine and India's rollout plan, the AIIMS Director said that he is hopeful that by the end of December or early January, emergency use authorisation will be received from Indian regulatory authorities


BusinessToday.In
November 24, 2020
Advertisement created a stir because COVID-19 vaccine is yet to be rolled out for masses, and Centre is working on a distribution system once vaccine is available


PAGES 1 OF 4  1234